790 related articles for article (PubMed ID: 29427237)
1. Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids.
Jackisch L; Kumsaiyai W; Moore JD; Al-Daghri N; Kyrou I; Barber TM; Randeva H; Kumar S; Tripathi G; McTernan PG
Diabetologia; 2018 May; 61(5):1155-1166. PubMed ID: 29427237
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children.
Sakka S; Siahanidou T; Voyatzis C; Pervanidou P; Kaminioti C; Lazopoulou N; Kanaka-Gantenbein C; Chrousos GP; Papassotiriou I
Clin Chem Lab Med; 2015 Jun; 53(7):1119-25. PubMed ID: 25581763
[TBL] [Abstract][Full Text] [Related]
3. Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study.
da Silva IT; Timm Ade S; Damasceno NR
Lipids Health Dis; 2013 Feb; 12():19. PubMed ID: 23413990
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitus.
Garg S; Madhu SV; Suneja S
Indian J Med Res; 2015 Jan; 141(1):107-14. PubMed ID: 25857502
[TBL] [Abstract][Full Text] [Related]
5. Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus.
Wootton PT; Stephens JW; Hurel SJ; Durand H; Cooper J; Ninio E; Humphries SE; Talmud PJ
Atherosclerosis; 2006 Nov; 189(1):149-56. PubMed ID: 16438975
[TBL] [Abstract][Full Text] [Related]
6. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
[TBL] [Abstract][Full Text] [Related]
7. Circulating Lp-PLA₂ activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapy.
Paik JK; Kim M; Kim M; Yen Y; Ahn HY; Lee SH; Lee JH
Age (Dordr); 2015; 37(2):32. PubMed ID: 25840804
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults.
Detopoulou P; Nomikos T; Fragopoulou E; Panagiotakos DB; Pitsavos C; Stefanadis C; Antonopoulou S
Lipids Health Dis; 2009 Jun; 8():19. PubMed ID: 19500354
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2?
Fratta Pasini A; Stranieri C; Pasini A; Vallerio P; Mozzini C; Solani E; Cominacini M; Cominacini L; Garbin U
PLoS One; 2013; 8(12):e83092. PubMed ID: 24358251
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.
Passaro A; Vigna GB; Romani A; Sanz JM; Cavicchio C; Bonaccorsi G; Valacchi G; Cervellati C
Oxid Med Cell Longev; 2018; 2018():1752940. PubMed ID: 30524650
[TBL] [Abstract][Full Text] [Related]
12. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].
Chen J; Cai HW; Miao J; Xu XM; Mao W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230
[TBL] [Abstract][Full Text] [Related]
13. Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes.
Sánchez-Quesada JL; Vinagre I; De Juan-Franco E; Sánchez-Hernández J; Bonet-Marques R; Blanco-Vaca F; Ordóñez-Llanos J; Pérez A
Cardiovasc Diabetol; 2013 Aug; 12():112. PubMed ID: 23915379
[TBL] [Abstract][Full Text] [Related]
14. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
[TBL] [Abstract][Full Text] [Related]
16. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
18. Effect of improving glycemic control in patients with type 2 diabetes mellitus on low-density lipoprotein size, electronegative low-density lipoprotein and lipoprotein-associated phospholipase A2 distribution.
Sánchez-Quesada JL; Vinagre I; de Juan-Franco E; Sánchez-Hernández J; Blanco-Vaca F; Ordóñez-Llanos J; Pérez A
Am J Cardiol; 2012 Jul; 110(1):67-71. PubMed ID: 22481012
[TBL] [Abstract][Full Text] [Related]
19. Interrelationships among platelet-activating factor and lipoprotein-associated phospholipase A
English CJ; Lohning AE; Mayr HL; Jones M; Reidlinger DP
Biofactors; 2023 Mar; 49(2):457-471. PubMed ID: 36538603
[TBL] [Abstract][Full Text] [Related]
20. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein-Associated Phospholipase A
Ntzouvani A; Giannopoulou E; Fragopoulou E; Nomikos T; Antonopoulou S
Lipids; 2019 Oct; 54(10):629-640. PubMed ID: 31489677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
